BPC-157 is primarily a research compound Evidence quality : Both lack large human clinical trials, but GHK-Cu has more human data for skin applications Conclusion# BPC-157 and GHK-Cu serve complementary rather than competing roles in tissue healing research
Ikuta, N., Sugiyama, H., Shimosegawa, H., Nakane, R., Ishida, Y., Uekaji, Y., Nakata, D., Pallauf, K., Rimbach, G., Terao, K., & Matsugo, S
Nausea: Particularly with oral administration
Ginsenoside Rg3 exhibits anti-fibrotic effects in both hepatic and cardiac tissues by modulating the TGF-/Smad signaling pathway
Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial
P.PhillipsK